Abstract 286: Metabolic alterations in skeletal muscle and serum of tumor-bearing cachectic mice

Abstract Cancer cachexia, a multifactorial syndrome characterized by systemic inflammation, high energy expenditure, and progressive skeletal muscle loss, poses a significant challenge in cancer management due to limited therapeutic options. Understanding the metabolic shifts associated with cachexia-related muscle wasting could provide critical insights into identifying potential biomarkers and therapeutic targets. In this study, we conducted targeted metabolomics to investigate metabolic alterations in the skeletal muscle and serum of tumor-bearing cachectic mice. To facilitate a comprehensive analysis, skeletal muscle samples from non-cachectic tumor-bearing mice were included to explore metabolic changes associated with tumor growth and its progression to cachexia. We found that tumor-bearing, non-cachectic muscles exhibited significantly higher levels of glucose-6-phosphate (G6P), fructose-6-phosphate with glucose-1-phosphate (F6P + G1P), glyceraldehyde-3-phosphate (G3P), glycerol-3-phosphate (Glycerol-3P), and phosphoenolpyruvate (PEP) compared to control muscles. However, no significant differences were observed between non-cachectic muscles and cachectic muscles. These findings indicate that increased glycolysis is more critical for tumor growth than for the progression to cachexia. Amino acids such as asparagine, alanine, and serine were significantly increased in cachectic muscle. Compared to non-cachectic muscle, levels of 2-hydroxyglutarate (2-HG) and CoA were decreased in cachectic skeletal muscle. Notably, alterations in 2-HG and CoA were consistent between muscle and serum, highlighting their potential as systemic biomarkers. These results reveal key metabolic alterations in skeletal muscle and serum associated with cancer cachexia, offering novel insights into the pathogenesis of muscle wasting and providing potential avenues for biomarker discovery and therapeutic intervention. Citation Format: Kuo-Chu Lai. Metabolic alterations in skeletal muscle and serum of tumor-bearing cachectic mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 286.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-286
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 286: Metabolic alterations in skeletal muscle and serum of tumor-bearing cachectic mice

Kuo‐Chu Lai
Cancer Research
Cancer, Hypoxia, and Metabolism
article

Abstract 286: Metabolic alterations in skeletal muscle and serum of tumor-bearing cachectic mice

Kuo‐Chu Lai
article en

Abstract

Abstract Cancer cachexia, a multifactorial syndrome characterized by systemic inflammation, high energy expenditure, and progressive skeletal muscle loss, poses a significant challenge in cancer management due to limited therapeutic options. Understanding the metabolic shifts associated with cachexia-related muscle wasting could provide critical insights into identifying potential biomarkers and therapeutic targets. In this study, we conducted targeted metabolomics to investigate metabolic alterations in the skeletal muscle and serum of tumor-bearing cachectic mice. To facilitate a comprehensive analysis, skeletal muscle samples from non-cachectic tumor-bearing mice were included to explore metabolic changes associated with tumor growth and its progression to cachexia. We found that tumor-bearing, non-cachectic muscles exhibited significantly higher levels of glucose-6-phosphate (G6P), fructose-6-phosphate with glucose-1-phosphate (F6P + G1P), glyceraldehyde-3-phosphate (G3P), glycerol-3-phosphate (Glycerol-3P), and phosphoenolpyruvate (PEP) compared to control muscles. However, no significant differences were observed between non-cachectic muscles and cachectic muscles. These findings indicate that increased glycolysis is more critical for tumor growth than for the progression to cachexia. Amino acids such as asparagine, alanine, and serine were significantly increased in cachectic muscle. Compared to non-cachectic muscle, levels of 2-hydroxyglutarate (2-HG) and CoA were decreased in cachectic skeletal muscle. Notably, alterations in 2-HG and CoA were consistent between muscle and serum, highlighting their potential as systemic biomarkers. These results reveal key metabolic alterations in skeletal muscle and serum associated with cancer cachexia, offering novel insights into the pathogenesis of muscle wasting and providing potential avenues for biomarker discovery and therapeutic intervention. Citation Format: Kuo-Chu Lai. Metabolic alterations in skeletal muscle and serum of tumor-bearing cachectic mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 286.

Cancer ResearchVol. 85(8_Supplement_1)
Chang Gung University (TW)
Openalex Percentile: Top 89%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.